Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019

This economic evaluation examines the magnitude and trend of prescription drug rebates in commercial markets from 2015 to 2019 and identifies insurance plan factors associated with rebates.

Detalles Bibliográficos
Autores principales: Plummer, Elizabeth, Socal, Mariana P., Ballreich, Jeromie M., Anderson, Gerard F., Bai, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077484/
https://www.ncbi.nlm.nih.gov/pubmed/35977258
http://dx.doi.org/10.1001/jamahealthforum.2022.0888
Descripción
Sumario:This economic evaluation examines the magnitude and trend of prescription drug rebates in commercial markets from 2015 to 2019 and identifies insurance plan factors associated with rebates.

Ejemplares similares